Weight Loss
Medical-grade GLP-1/GIP solutions and advanced metabolic support for sustainable weight management and body recomposition.
Weight Loss Peptide Collection
Medical-Grade Metabolic Transformation Solutions
Semaglutide
GLP-1 Receptor Agonist
Primary Uses
Weight loss, blood sugar regulation (T2D), and may support inflammation reduction, PCOS management, and metabolic syndrome.
Key Benefits
- Appetite suppression
- Delayed gastric emptying
- Improved glycemic control
- Reduced risk of heart disease
- Inflammation reduction
Men-Specific Benefits
Supports fat loss with preservation of lean muscle, helps reduce visceral fat linked to metabolic syndrome.
Women-Specific Benefits
May regulate appetite swings tied to hormonal cycles, supports fat loss with preservation of lean muscle, helps to reduce symptoms of perimenopause & menopause.
Potential Side Effects
Nausea, vomiting, constipation - typically mild and improve over time.
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist
What Makes It Special
Tirzepatide is a cutting-edge medication that targets two powerful metabolic pathways to support weight loss, blood sugar control, and overall metabolic health. It's known as a dual GIP/GLP-1 receptor agonist—meaning it mimics two natural hormones involved in appetite regulation and insulin sensitivity.
Primary Uses
Weight loss and blood sugar control with superior results compared to single-pathway medications.
Key Benefits
- More potent appetite suppression vs. semaglutide
- May improve insulin sensitivity
- Improves overall metabolic health
- May support inflammation reduction
- PCOS management
- Metabolic syndrome improvement
Men-Specific Benefits
Enhances metabolic flexibility, supports strength training by reducing body fat, improves metabolic health.
Women-Specific Benefits
Rapid fat loss in stubborn areas, can assist in weight loss resistant to diet/exercise alone due to hormones, helps to reduce symptoms of perimenopause & menopause, improves metabolic health.
Side Effects
Similar to semaglutide but often better tolerated due to gradual dose escalation.
Retatrutide
Triple Receptor Agonist
The Next Generation
Retatrutide is a next-generation weight loss medication that targets three metabolic receptors—GLP-1, GIP, and glucagon—making it one of the most powerful peptide-based therapies currently in development.
It's sometimes referred to as the "triple agonist" because of its multi-receptor activity, giving it a broader impact on appetite, metabolism, and fat burning than other medications like Semaglutide or Tirzepatide.
Primary Uses
Next-gen weight loss treatment for people focused on fat loss specifically, with the most dramatic results seen to date.
Key Benefits
- Multi-receptor activity for superior fat loss
- Increased resting energy expenditure
- Enhanced metabolic rate
- Most significant weight loss results of any peptide
- Targets multiple metabolic pathways simultaneously
Men-Specific Benefits
Aggressive fat loss with metabolic boost, ideal for those seeking maximum transformation results.
Women-Specific Benefits
Helps target hormonal weight retention zones that are typically resistant to traditional weight loss methods.
Important Notes
GI upset possible, potential increase in heart rate. Currently in clinical trials, not yet FDA-approved for weight loss.